» Articles » PMID: 29950411

Human MxB Protein Is a Pan-herpesvirus Restriction Factor

Abstract

Herpesvirus infections are highly prevalent in the human population and persist for life. They are often acquired subclinically but potentially progress to life-threatening diseases in immunocompromised individuals. The interferon system is indispensable for the control of herpesviral replication. However, the responsible antiviral effector mechanisms are not well characterized. The type I interferon-induced, human myxovirus resistance 2 () gene product MxB, a dynamin-like large GTPase, has recently been identified as a potent inhibitor of HIV-1. We now show that MxB also interferes with an early step of herpesvirus replication, affecting alpha-, beta-, and gammaherpesviruses before or at the time of immediate early gene expression. Defined MxB mutants influencing GTP binding and hydrolysis revealed that the effector mechanism against herpesviruses is thoroughly different from that against HIV-1. Overall, our findings demonstrate that MxB serves as a broadly acting intracellular restriction factor that controls the establishment of not only retrovirus but also herpesvirus infection of all three subfamilies. Human herpesviruses pose a constant threat to human health. Reactivation of persisting herpesvirus infections, particularly in immunocompromised individuals and the elderly, can cause severe diseases, such as zoster, pneumonia, encephalitis, or cancer. The interferon system is relevant for the control of herpesvirus replication as exemplified by fatal disease outcomes in patients with primary immunodeficiencies. Here, we describe the interferon-induced, human gene product MxB as an efficient restriction factor of alpha-, beta-, and gammaherpesviruses. MxB has previously been described as an inhibitor of HIV-1. Importantly, our mutational analyses of MxB reveal an antiviral mechanism of herpesvirus restriction distinct from that against HIV-1. Thus, the dynamin-like MxB GTPase serves as a broadly acting intracellular restriction factor that controls retrovirus as well as herpesvirus infections.

Citing Articles

Antiviral Mx proteins have an ancient origin and widespread distribution among eukaryotes.

Langley C, Dietzen P, Emerman M, Tenthorey J, Malik H Proc Natl Acad Sci U S A. 2025; 122(4):e2416811122.

PMID: 39854241 PMC: 11789081. DOI: 10.1073/pnas.2416811122.


Recent updates of interferon-derived myxovirus resistance protein A as a biomarker for acute viral infection.

Abebaw D, Akelew Y, Adugna A, Teffera Z, Belew H, Selabat B Eur J Med Res. 2024; 29(1):612.

PMID: 39710743 PMC: 11665083. DOI: 10.1186/s40001-024-02221-8.


Antiviral Mx proteins have an ancient origin and widespread distribution among eukaryotes.

Langley C, Dietzen P, Emerman M, Tenthorey J, Malik H bioRxiv. 2024; .

PMID: 39149278 PMC: 11326297. DOI: 10.1101/2024.08.06.606855.


Construction and Characterization of a High-Capacity Replication-Competent Murine Cytomegalovirus Vector for Gene Delivery.

Riedl A, Bojkova D, Tan J, Jeney A, Larsen P, Jeney C Vaccines (Basel). 2024; 12(7).

PMID: 39066429 PMC: 11281640. DOI: 10.3390/vaccines12070791.


Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.

Layish B, Goli R, Flick H, Huang S, Zhang R, Kvaratskhelia M PLoS Pathog. 2024; 20(3):e1011830.

PMID: 38512975 PMC: 10986937. DOI: 10.1371/journal.ppat.1011830.


References
1.
Victoria J, Luiz Sena Guimaraes A, da Silva L, Kalapothakis E, Gomez R . Polymerase chain reaction for identification of herpes simplex virus (HSV-1), cytomegalovirus (CMV) and human herpes virus-type 6 (HHV-6) in oral swabs. Microbiol Res. 2005; 160(1):61-5. DOI: 10.1016/j.micres.2004.09.011. View

2.
Jordan S, Krause J, Prager A, Mitrovic M, Jonjic S, Koszinowski U . Virus progeny of murine cytomegalovirus bacterial artificial chromosome pSM3fr show reduced growth in salivary Glands due to a fixed mutation of MCK-2. J Virol. 2011; 85(19):10346-53. PMC: 3196435. DOI: 10.1128/JVI.00545-11. View

3.
Shalem O, Sanjana N, Hartenian E, Shi X, Scott D, Mikkelson T . Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2013; 343(6166):84-87. PMC: 4089965. DOI: 10.1126/science.1247005. View

4.
King M, Raposo G, Lemmon M . Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB. Proc Natl Acad Sci U S A. 2004; 101(24):8957-62. PMC: 428454. DOI: 10.1073/pnas.0403167101. View

5.
Cicin-Sain L, Bubic I, Schnee M, Ruzsics Z, Mohr C, Jonjic S . Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy. J Virol. 2007; 81(24):13825-34. PMC: 2168857. DOI: 10.1128/JVI.01911-07. View